Camargo Pharmaceutical Services, a global drug development strategist specializing in the 505(b)(2) approval pathway, has appointed Marc Wiles as vice president, scientific and regulatory affairs, and Suzanne Beck as director, contracts and legal projects. With more than 20 years of experience in drug development, Mr. Wiles brings extensive technical and regulatory expertise to Camargo in assessing, developing and registering therapeutic products. He has demonstrated success across the full l...